Back Pain News and Research

Latest Back Pain News and Research

Utah-based company licenses new biomedical device from BYU for chronic back pain

In between the vertebrae of the human spine are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together and allow for spine movement. While the discs are critical for movement, they can become the source of back pain when they degenerate or herniate - a major health problem that affects 85% of Americans and drains the U.S. economy to the tune of $100 billion every year.

13 Jun 2012

Acorda commences AMPYRA clinical study for post-stoke deficits

Acorda Therapeutics, Inc. today announced that the first patient has been enrolled in a proof-of-concept study exploring the use of AMPYRA(dalfampridine) Extended Release Tablets, 10 mg in treating patients who have post-stroke deficits.

13 Jun 2012

Theramine may reduce chronic low back pain

Physician Therapeutics, Inc., a division of Targeted Medical Pharma, Inc., a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians, pharmacies and skilled nursing facilities, published results from a clinical trial of the company's proprietary medical food Theramine.

11 Jun 2012

Dapagliflozin more effective than sitagliptin for adult patients with type 2 diabetes

Bristol-Myers Squibb Company and AstraZeneca today announced results from a Phase 3 clinical study that showed the investigational compound dapagliflozin 10 mg demonstrated significant reductions in blood sugar levels (glycosylated hemoglobin levels, or HbA1c) compared with placebo at 24 weeks when either agent was added to existing sitagliptin therapy (with or without metformin) in adult patients with type 2 diabetes.

11 Jun 2012

Adolescent mental disorders have repercussions for addiction

Adolescents with mental health disorders are significantly more likely to become addicted to prescription opioid pain relievers than those without mental disorders, experts say.

8 Jun 2012

Experts debate whether spinal manipulation for neck pain should be abandoned

The effectiveness of spinal manipulation divides medical opinion. On bmj.com today, experts debate whether spinal manipulation for neck pain should be abandoned.

8 Jun 2012

Young adults, adolescents with mental health disorders more likely to become long-term opioid users

Long-term use and abuse of opioid painkillers, such as OxyContin and Vicodin, has markedly increased in the United States in the last two decades. Of note, prescription opioids constitute 86.9 percent of prescription drug misuse among high school students. And last week in a two-day U.S. Food and Drug Administration public meeting, officials questioned the use of long-term opioids for chronic pain due to a lack of evidence for the effectiveness and concerns about the potential risk for addiction.

7 Jun 2012

Abbott announces results from HUMIRA Phase 3 study on axSpA

Abbott today announced results from the open-label extension of the Phase 3 ABILITY-1 investigational study of HUMIRA (adalimumab), which assessed the improvement in signs and symptoms of disease for patients with active axial spondyloarthritis (axSpA) who have no X-ray evidence of structural damage.

6 Jun 2012

Positive updated interim data from Exelixis’ cabozantinib phase 2 trial on CRPC

Exelixis, Inc. today reported positive updated interim data from an ongoing phase 2 trial of cabozantinib in men with metastatic castration-resistant prostate cancer (CRPC) and bone metastases.

6 Jun 2012

Cardinal Health to produce new AD diagnostic imaging agent, Amyvid

Cardinal Health today announced that it will manufacture and distribute Amyvid, Eli Lilly and Company's new diagnostic imaging agent that aids in the evaluation of adult patients with cognitive impairment who are being evaluated for Alzheimer's Disease and other causes of cognitive decline. The commercial launch of Amyvid is scheduled for June 1, 2012.

2 Jun 2012

$Vertebroplasty feasible for at least 1 year after fracture$

Vertebroplasty feasible for at least 1 year after fracture

Patients with subacute and chronic osteoporotic vertebral compression fractures can be successfully treated with percutaneous vertebroplasty between 2 and 12 months after symptom onset, say researchers.

31 May 2012

Acorda Therapeutics launches Ampyra Dialogues on World MS Day

Acorda Therapeutics, Inc., makers of Ampyra (dalfampridine), today announced the launch of Ampyra Dialogues, the first-ever online talk show where patients and medical experts talk about how walking problems affect people living with MS.

31 May 2012

Abbott to highlight latest investigational research findings on HUMIRA at EULAR 2012

Abbott scientists and independent researchers will highlight the latest investigational research findings on HUMIRA (adalimumab) at the European League Against Rheumatism (EULAR) Congress in Berlin, Germany, from 6-9 June, 2012.

29 May 2012

EMA CHMP adopts positive opinion for Pfizer’s axitinib to treat advanced renal cell carcinoma

Pfizer announced today that the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion regarding the marketing authorization of axitinib in the European Union (EU), for the treatment of adult patients with advanced renal cell carcinoma (RCC), a type of advanced kidney cancer, after failure of prior treatment with sunitinib or a cytokine.

25 May 2012

Nevro to initiate Senza HF-SCS System study for chronic pain

Nevro Corp., a medical device company focused on achieving improved pain relief for patients suffering from debilitating chronic pain, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for initiation of its SENZA-RCT study, a U.S. prospective, randomized, controlled pivotal clinical trial evaluating the safety and efficacy of Nevro's high-frequency spinal cord stimulation system for the treatment of chronic pain.

24 May 2012

Exercise can add years to a person's life

A recent study has shown that exercise can add years to a person's life. Still, as we age it can become more tedious and sometimes more difficult to exercise.

23 May 2012

Enrollment complete in Baxano’s iO-Flex System study

Baxano, Inc., a Silicon Valley based medical device company and manufacturer of the iO-Flex System used in spinal decompression surgery, today announced it has completed enrollment in its iO-Flex Study.

23 May 2012

Massage therapy effective for knee osteoarthritis, chronic low back pain and fibromyalgia

A growing body of evidence shows massage therapy can be effective for a variety of prevalent health conditions, including the pain of osteoarthritis of the knee, inflammation after exercise, chronic low back pain and fibromyalgia.

21 May 2012

APS honors recipients of Clinical Centers of Excellence in Pain Management Awards

The American Pain Society (APS), honored the recipients of its sixth annual Clinical Centers of Excellence in Pain Management Awards recognizing the nation's outstanding pain care centers.

19 May 2012

Study focuses on role of the brain and mind in chronic and complex pain disorders

Training the brain to reduce pain could be a promising approach for treating phantom limb pain and complex regional pain syndrome, according to an internationally known neuroscience researcher speaking today at the American Pain Society's Annual Scientific Meeting.

19 May 2012

Back Pain News and Research

Latest Back Pain News and Research

Utah-based company licenses new biomedical device from BYU for chronic back pain

Acorda commences AMPYRA clinical study for post-stoke deficits

Theramine may reduce chronic low back pain

Dapagliflozin more effective than sitagliptin for adult patients with type 2 diabetes

Adolescent mental disorders have repercussions for addiction

Experts debate whether spinal manipulation for neck pain should be abandoned

Young adults, adolescents with mental health disorders more likely to become long-term opioid users

Abbott announces results from HUMIRA Phase 3 study on axSpA

Positive updated interim data from Exelixis’ cabozantinib phase 2 trial on CRPC

Cardinal Health to produce new AD diagnostic imaging agent, Amyvid

Vertebroplasty feasible for at least 1 year after fracture

Acorda Therapeutics launches Ampyra Dialogues on World MS Day

Abbott to highlight latest investigational research findings on HUMIRA at EULAR 2012

EMA CHMP adopts positive opinion for Pfizer’s axitinib to treat advanced renal cell carcinoma

Nevro to initiate Senza HF-SCS System study for chronic pain

Exercise can add years to a person's life

Enrollment complete in Baxano’s iO-Flex System study

Massage therapy effective for knee osteoarthritis, chronic low back pain and fibromyalgia

APS honors recipients of Clinical Centers of Excellence in Pain Management Awards

Study focuses on role of the brain and mind in chronic and complex pain disorders

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Back Pain News and Research

Latest Back Pain News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in